[1] XU JJ, ZHANG Y, JIANG L, et al.Comparison of long-term outcomes in patients with premature triple-vessel coronary disease undergoing three different treatment strategies:a prospective cohort study[J].Chin Med J, 2018, 131(1):1. doi: 10.4103/0366-6999.221273
[2] SILVA D, LACERDA APD.High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease[J].Rev Port Cardiol, 2012, 31(11):733. doi: 10.1016/j.repc.2012.02.018
[3] 许艺博.冠心病发病风险预测模型及筛查模型研究[J].济南:山东大学, 2017.
[4] 孙丽娜, 范新俊.早发冠心病病人危险因素分析及冠脉病变特点研究[J].安徽医药, 2018, 22(4):692. doi: 10.3969/j.issn.1009-6469.2018.04.030
[5] 郑宏, 张丽莉, 李艳华.早发冠心病临床危险因素分析及其与预后的相关性探讨[J].中国卫生统计, 2013, 30(3):382.
[6] 王莉娜, 顾丽华, 智宏, 等.南京市社区居民早发冠心病现况及高危因素研究[J].江苏医药, 2010, 36(17):1989.
[7] RIZZO M, KOTUR-STEVULJEVIC J, BERNEIS K, et al.Atherogenic dyslipidemia and oxidative stress:a new look[J].Transl Res, 2009, 153(5):217. doi: 10.1016/j.trsl.2009.01.008
[8] 刘炎, 蔡安平, 周颖玲.早发冠状动脉粥样硬化性心脏病病因及危险因素研究进展[J].岭南心血管病杂志, 2017, 23(5):643. doi: 10.3969/j.issn.1007-9688.2017.05.40
[9] TORPY JM, BURKE AE, GLASS RM.JAMA patient page.Coronary heart disease risk factors[J].JAMA, 2009, 302(21):2388. doi: 10.1001/jama.302.21.2388